Multimodal comparisons of QSM and PET in neurodegeneration and aging
Quantitative susceptibility mapping (QSM) has been used to study susceptibility changes that may occur based on tissue composition and mineral deposition. Iron is a primary contributor to changes in magnetic susceptibility and of particular interest in applications of QSM to neurodegeneration and ag...
| Published in: | NeuroImage |
|---|---|
| Main Authors: | Petrice M. Cogswell, Audrey P. Fan |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-06-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1053811923002148 |
Similar Items
Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook
by: Miriam Conte, et al.
Published: (2023-05-01)
by: Miriam Conte, et al.
Published: (2023-05-01)
Direct comparison between 18F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy
by: Ryota Satoh, et al.
Published: (2024-02-01)
by: Ryota Satoh, et al.
Published: (2024-02-01)
Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study
by: Tanja Blume, et al.
Published: (2018-11-01)
by: Tanja Blume, et al.
Published: (2018-11-01)
Artificial Intelligence in PET Imaging for Alzheimer’s Disease: A Narrative Review
by: Andrea Marongiu, et al.
Published: (2025-09-01)
by: Andrea Marongiu, et al.
Published: (2025-09-01)
Relationship between tau-PET and quantitative susceptibility mapping in atypical Alzheimer’s disease
by: Neha Singh-Reilly, et al.
Published: (2025-07-01)
by: Neha Singh-Reilly, et al.
Published: (2025-07-01)
Visual reading for [18F]Florzolotau ([18F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
by: Huan-Chun Lin, et al.
Published: (2023-05-01)
by: Huan-Chun Lin, et al.
Published: (2023-05-01)
A feasibility study for quantitative assessment of cerebrovascular malformations using flutriciclamide ([18F]GE-180) PET/MRI
by: Sally Ji Who Kim, et al.
Published: (2023-04-01)
by: Sally Ji Who Kim, et al.
Published: (2023-04-01)
Feasibility of radiomic feature harmonization for pooling of [18F]FET or [18F]GE-180 PET images of gliomas
by: Adrian Jun Zounek, et al.
Published: (2023-02-01)
by: Adrian Jun Zounek, et al.
Published: (2023-02-01)
Implication of tau propagation on neurodegeneration in Alzheimer’s disease
by: Daniel Lamontagne-Kam, et al.
Published: (2023-07-01)
by: Daniel Lamontagne-Kam, et al.
Published: (2023-07-01)
Analysis of imaging signatures in 18F-DOPA PET of glioblastoma treated with dose-escalated radiotherapy
by: Jing Qian, et al.
Published: (2025-08-01)
by: Jing Qian, et al.
Published: (2025-08-01)
Assessment of basal TSPO expression and [18F]DPA-714 biodistribution in healthy mice and post-ischemic brain using PET imaging
by: Brígida Gomes de Almeida Schirmer, et al.
Published: (2025-04-01)
by: Brígida Gomes de Almeida Schirmer, et al.
Published: (2025-04-01)
Synthesis and evaluation of TSPO-targeting radioligand [18F]F-TFQC for PET neuroimaging in epileptic rats
by: Wenhui Fu, et al.
Published: (2025-02-01)
by: Wenhui Fu, et al.
Published: (2025-02-01)
The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI
by: Giulia Santo, et al.
Published: (2022-03-01)
by: Giulia Santo, et al.
Published: (2022-03-01)
Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
by: DL Tudorascu, et al.
Published: (2020-01-01)
by: DL Tudorascu, et al.
Published: (2020-01-01)
APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly
by: Anniina Snellman, et al.
Published: (2023-04-01)
by: Anniina Snellman, et al.
Published: (2023-04-01)
Translocator protein PET imaging in temporal lobe epilepsy: A reliable test-retest study using asymmetry index
by: Mohammad Mahmud, et al.
Published: (2023-04-01)
by: Mohammad Mahmud, et al.
Published: (2023-04-01)
Editorial: Utilization of Hybrid PET/MR in Neuroimaging
by: Masoud Tahmasian, et al.
Published: (2015-07-01)
by: Masoud Tahmasian, et al.
Published: (2015-07-01)
Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson’s disease
by: Angelina R.A. Pikstra, et al.
Published: (2016-01-01)
by: Angelina R.A. Pikstra, et al.
Published: (2016-01-01)
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration
by: Rory Boyle, et al.
Published: (2024-07-01)
by: Rory Boyle, et al.
Published: (2024-07-01)
The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
by: Rola Ismail, et al.
Published: (2020-05-01)
by: Rola Ismail, et al.
Published: (2020-05-01)
A blood-free modeling approach for the quantification of the blood-to-brain tracer exchange in TSPO PET imaging
by: Lucia Maccioni, et al.
Published: (2024-07-01)
by: Lucia Maccioni, et al.
Published: (2024-07-01)
FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer’s Disease: Benefits and Pitfalls
by: Poul F. Høilund-Carlsen, et al.
Published: (2023-07-01)
by: Poul F. Høilund-Carlsen, et al.
Published: (2023-07-01)
Accounting for white matter uptake improves between tracer agreement in amyloid PET
by: Yinghua Chen, et al.
Published: (2025-07-01)
by: Yinghua Chen, et al.
Published: (2025-07-01)
Relevance of Dynamic <sup>18</sup>F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes
by: Shamimeh Ahrari, et al.
Published: (2021-12-01)
by: Shamimeh Ahrari, et al.
Published: (2021-12-01)
Evaluation of a novel PET tracer [18F]-Florbetazine for Alzheimer's disease diagnosis and β-amyloid deposition quantification
by: Meiqi Wu, et al.
Published: (2024-09-01)
by: Meiqi Wu, et al.
Published: (2024-09-01)
Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
by: Xue‐Ning Shen, et al.
Published: (2021-01-01)
by: Xue‐Ning Shen, et al.
Published: (2021-01-01)
<sup>18</sup>F-Radiolabeled Translocator Protein (TSPO) PET Tracers: Recent Development of TSPO Radioligands and Their Application to PET Study
by: Truong Giang Luu, et al.
Published: (2022-11-01)
by: Truong Giang Luu, et al.
Published: (2022-11-01)
An automatic pipeline for PET/MRI attenuation correction validation in the brain
by: Mahdjoub Hamdi, et al.
Published: (2023-11-01)
by: Mahdjoub Hamdi, et al.
Published: (2023-11-01)
Association of the digital clock drawing test with amyloid and tau PET biomarkers in low age risk adults
by: Huitong Ding, et al.
Published: (2025-04-01)
by: Huitong Ding, et al.
Published: (2025-04-01)
Generation of synthetic TSPO PET maps from structural MRI images
by: Matteo Ferrante, et al.
Published: (2025-09-01)
by: Matteo Ferrante, et al.
Published: (2025-09-01)
Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models
by: Anne Nack, et al.
Published: (2019-01-01)
by: Anne Nack, et al.
Published: (2019-01-01)
A Systematic Review on Dementia and Translocator Protein (TSPO): When Nuclear Medicine Highlights an Underlying Expression
by: Miriam Conte, et al.
Published: (2023-03-01)
by: Miriam Conte, et al.
Published: (2023-03-01)
Microglia activation in a pediatric rabbit model of tuberculous meningitis
by: Elizabeth W. Tucker, et al.
Published: (2016-12-01)
by: Elizabeth W. Tucker, et al.
Published: (2016-12-01)
The Molecular Effects of Ionizing Radiations on Brain Cells: Radiation Necrosis vs. Tumor Recurrence
by: Vincenzo Cuccurullo, et al.
Published: (2019-09-01)
by: Vincenzo Cuccurullo, et al.
Published: (2019-09-01)
Progress and challenges in pet management in disasters: recommended strategies for developing countries - a scoping review
by: Shandiz Moslehi, et al.
Published: (2025-10-01)
by: Shandiz Moslehi, et al.
Published: (2025-10-01)
Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data
by: Granville J. Matheson, et al.
Published: (2017-07-01)
by: Granville J. Matheson, et al.
Published: (2017-07-01)
Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases
by: Sonja Daerr, et al.
Published: (2017-01-01)
by: Sonja Daerr, et al.
Published: (2017-01-01)
Amelioration of Pet Overpopulation and Abandonment Using Control of Breeding and Sale, and Compulsory Owner Liability Insurance
by: Eva Bernete Perdomo, et al.
Published: (2021-02-01)
by: Eva Bernete Perdomo, et al.
Published: (2021-02-01)
FDG-PET AND PET/CT - Part I
by: Amol M Takalkar, et al.
Published: (2007-07-01)
by: Amol M Takalkar, et al.
Published: (2007-07-01)
Extension of microglial activation is associated with epilepsy and cognitive dysfunction in Tuberous sclerosis complex: A TSPO-PET study
by: Kuriko Kagitani-Shimono, et al.
Published: (2023-01-01)
by: Kuriko Kagitani-Shimono, et al.
Published: (2023-01-01)
Similar Items
-
Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook
by: Miriam Conte, et al.
Published: (2023-05-01) -
Direct comparison between 18F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy
by: Ryota Satoh, et al.
Published: (2024-02-01) -
Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study
by: Tanja Blume, et al.
Published: (2018-11-01) -
Artificial Intelligence in PET Imaging for Alzheimer’s Disease: A Narrative Review
by: Andrea Marongiu, et al.
Published: (2025-09-01) -
Relationship between tau-PET and quantitative susceptibility mapping in atypical Alzheimer’s disease
by: Neha Singh-Reilly, et al.
Published: (2025-07-01)
